Literature DB >> 16255667

Drug-induced diabetes mellitus.

Hassane Izzedine1, Vincent Launay-Vacher, Camille Deybach, Edward Bourry, Benoit Barrou, Gilbert Deray.   

Abstract

AIMS: To review the medications that influence glucose metabolism with a focus on hypertensive, transplant and HIV-infected patient populations.
METHODS: Literature obtained from a MEDLINE search from 1970 to present, including studies published in the English language. The search strategy linked drugs, hyperglycaemia and diabetes mellitus, HIV, transplantation, hypertension and psychiatric patients.
RESULTS: Many common therapeutic agents influence glucose metabolism. Multiple mechanisms of action on glucose metabolism exist through pancreatic, hepatic and peripheral effects. The prevalence of hyperglycaemia was higher with the use of thiazide diuretic, beta-blocker, calcineurin, protease inhibitors and atypical antipsychotic drugs.
CONCLUSIONS: Patients treated with those drugs appear to be at increased risk for developing diabetes. It is prudent to monitor plasma glucose values when it is not possible to avoid prescription of medication with known effects on carbohydrate metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16255667     DOI: 10.1517/14740338.4.6.1097

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  10 in total

Review 1.  Pharmacologically-induced metabolic acidosis: a review.

Authors:  George Liamis; Haralampos J Milionis; Moses Elisaf
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

2.  Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort.

Authors:  Tanushree Haldar; Akinyemi Oni-Orisan; Thomas J Hoffmann; Catherine Schaefer; Carlos Iribarren; Ronald M Krauss; Marisa W Medina; Neil Risch
Journal:  Cardiovasc Diabetol       Date:  2022-07-14       Impact factor: 8.949

3.  Understanding the social factors that contribute to diabetes: a means to informing health care and social policies for the chronically ill.

Authors:  Jacqueline Hill; Marcia Nielsen; Michael H Fox
Journal:  Perm J       Date:  2013

4.  Octreotide long-acting release (LAR) in combination with other therapies for treatment of neuroendocrine neoplasia: a systematic review.

Authors:  Maria Rinzivillo; Ilaria De Felice; Ludovica Magi; Bruno Annibale; Francesco Panzuto
Journal:  J Gastrointest Oncol       Date:  2021-04

5.  Drug-induced diabetes type 2: In silico study involving class B GPCRs.

Authors:  Dorota Latek; Ewelina Rutkowska; Szymon Niewieczerzal; Judyta Cielecka-Piontek
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

Review 6.  Combine and Conquer: With Type 2 Diabetes Polypharmacy Is Essential Not Only to Achieve Glycemic Control but Also to Treat the Comorbidities and Stabilize or Slow the Advancement of Diabetic Nephropathy.

Authors:  David S H Bell
Journal:  J Diabetes Res       Date:  2022-08-04       Impact factor: 4.061

7.  Hyperglycemia related to high-dose glucocorticoid use in noncritically ill patients.

Authors:  Jose Gerardo Gonzalez-Gonzalez; Leonor Guadalupe Mireles-Zavala; Rene Rodriguez-Gutierrez; David Gomez-Almaguer; Fernando Javier Lavalle-Gonzalez; Hector Eloy Tamez-Perez; Gerardo Gonzalez-Saldivar; Jesus Zacarias Villarreal-Perez
Journal:  Diabetol Metab Syndr       Date:  2013-04-04       Impact factor: 3.320

8.  Disease history and medication use as risk factors for the clinical manifestation of type 1 diabetes in children and young adults: an explorative case control study.

Authors:  Soulmaz Fazeli Farsani; Patrick C Souverein; Marja M J van der Vorst; Aukje K Mantel-Teeuwisse; Catherijne A J Knibbe; Anthonius de Boer
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

9.  Potential off-target effects of beta-blockers on gut hormone receptors: In silico study including GUT-DOCK-A web service for small-molecule docking.

Authors:  Pawel Pasznik; Ewelina Rutkowska; Szymon Niewieczerzal; Judyta Cielecka-Piontek; Dorota Latek
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

Review 10.  Diabetes and tuberculosis: a syndemic complicated by COVID-19.

Authors:  Violeta Antonio-Arques; Josep Franch-Nadal; Joan A Caylà
Journal:  Med Clin (Barc)       Date:  2021-05-06       Impact factor: 1.725

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.